Articles written by Priya Nigam - Benzinga

Oracle Rides Strong On The AI Wave, Despite Q4 Revenue Miss: 8 Analysts' Insights

Oracle's Q4 results reveal strong performance in AI sector, with analysts predicting continued growth and raising price targets for stock.

Why NextEra Energy Raises Forecast After Analyst Day

NextEra Energy raises forecast after Analyst Day. Goldman Sachs maintains Buy rating with $81 price target.

Expectations For Adobe's Q2 Results Are 'Depressed': JPMorgan

Adobe stock has been on a downtrend since its previous quarter results. Expectations for the quarter remains low, reflecting concerns around monetizing AI.

Phillips 66 Deploys Asset Base 'Near Historical Highs' To Meet Peak Summer Demand: Analyst

Phillips 66 is focusing on reducing its run-rate costs. The company expects to deploy its asset base at near historical highs.

Rocket Lab USA: Space Launch Business To Drive Operational Leverage

Rocket Lab USA's launch business could drive operating leverage, while the products business continues to grow.

Oracle Q4 Preview: 73% Datapoints Are Positive, Says This Analyst

Of the 26 datapoints collated ahead of Oracle's fiscal fourth-quarter results, 73% are positive, according to JMP Securities.

Cisco Systems Guidance Understates New Growth Initiatives, Says Bullish Analyst

Cisco Systems expects AI-related orders to surpass $1 billion by fiscal 2025; revenue conversion will commence in the first half of the year.

Broadcom Could Report A Modest Beat For Q2, Says Bullish Analyst

Bullish analyst expects modest beat for Broadcom in Q2 earnings, citing strength in AI. Price target at $1,680.

Datadog Has A 'Clear Vision On AI,' Says Bullish Analyst

Datadog's investor day meeting highlight the company's strong AI position and 20% long-term growth potential.

Nio's Units Ramp But Margins Remain Pressured: Analysts Provide Q1 Takeaways

Nio's Q1 results showed a 7% YOY decline in revenues and 201% growth in gross profits. Analysts remain neutral, as the company's margins continue to be under pressure even as deliveries and revenues ramp.

Ciena Sees 'Early Signs Of A Recovery,' 3 Analysts Dive Into Q2 Results

Ciena shows early signs of recovery and positive analyst takeaways. Yet, its share price declined and analysts lowered their forecasts.

DocuSign Reports A 'Skinny Beat' With 'Street's Calibration To The New Cadence May Take A Quarter Or Two'

DocuSign reported upbeat Q1 results, but the beat was less than in previous quarters. Management issued tempered expectations for near-term growth. Analysts have mixed opinions.

Stitch Fix's Results Show 'Green Shoots' Emerging: Analysts Take A Look While Stock Jumps Higher

Stitch Fix reports better-than-expected Q3 results, but analysts remain cautious about declining active clients and elevated acquisition costs.

CrowdStrike Outperforms Peers Against Tough Macro In Q1, 10 Analysts Comment On 'Top Name To Own In Security'

"We continue to be encouraged by the strength in [CrowdStrike's] underlying business," Truist Securities noted.

PVH, Parent Of Calvin Klein, Tommy Hilfiger, Impresses Analysts With Q1 Earnings Beat

PVH Corp's stock climbs after upbeat Q1 earnings report. Although revenues declined, they were broadly as expected. The company raised its FY outlook.

Superior Group Of Companies Set For Growth In $4B Healthcare Apparel Market: Analyst

Superior Group of Companies (NASDAQ: SGC) climbs on positive outlook from analyst Keegan Cox, citing growth potential in healthcare apparel and branded products.

Sunoco, NuStar Acquisition Concerns 'Do Not Justify Stock's Underperformance': Analyst

Sunoco has underperformed since March. It's down 22%, despite the company's "fundamental tailwinds," according to Mizuho Securities.

This MedTech Company Has Market Expansion Opportunity, Says Bullish Analyst

Strong data from TransMedics' clinical trials is expected to drive adoption. Longer-term, the annual market opportunity is $1.5 billion.

Goldman Sachs Has Potential For Significant Alpha Generation: Analyst

Goldman Sachs has a Buy rating and price target of $525; Shares declined by 0.9% to $452.47 at last check on Monday.

Ulta Beauty To Recover In Second Half Of 2024: 8 Analysts Dissect Q1 Results

Ulta Beauty's Q1 results beat expectations, but lowered guidance due to competitive pressure. Some analysts have revised forecasts.